Berry Genomics Co., Ltd.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Jan 2032
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Oct 16, 2027The maintenance fee for Method for determining content of cell-free fetal DNA and device for implementing method (US 11,959,128) comes due Oct 16, 2027. Unpaid by Apr 17, 2028, it lapses early.
- 1 fee due Nov 12, 2027The maintenance fee for Method and kit for non-invasively detecting EGFR gene mutations (US 10,648,037) comes due Nov 12, 2027. Unpaid by May 12, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 7 of 7
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,227,587 | Method for Constructing a Plasma DNA Sequencing Library In force · Medium confidence | In force | Medium confidence | |
| US 9,540,687 | DNA fragment detection method, DNA fragment detection kit and the use thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 9,885,080 | Kit, a device and a method for detecting copy number of fetal chromosomes or tumor cell chromosomes In force · From the USPTO record | In force | From the USPTO record | |
| US 10,648,037 | Method and kit for non-invasively detecting EGFR gene mutations In force · From the USPTO record | In force | From the USPTO record | |
| US 11,535,884 | Methods and kits for targeted enrichment of target DNA with high GC content In force · From the USPTO record | In force | From the USPTO record | |
| US 11,959,128 | Method for determining content of cell-free fetal DNA and device for implementing method In force · From the USPTO record | In force | From the USPTO record | |
| US 12,098,367 | Argonaute Protein Mutant and Use Thereof In force · High confidence | In force | High confidence |
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
9 no status recorded